| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
July 20, 2022
Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate...
-
May 31, 2022
Beckman Coulter, a global clinical diagnostics leader, announces a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood collection and...
-
March 15, 2022
O acordo de distribuição global com a Saladax Biomedical disponibiliza ensaios de monitorização de medicamentos terapêuticos antipsicóticos aos clientes da Beckman Coulter Lisboa, 15 de...
-
March 15, 2022
L’accordo con Saladax Biomedical per la distribuzione a livello mondiale porterà i test di monitoraggio per i farmaci terapeutici antipsicotici ai clienti Beckman Coulter Milano, 15 marzo 2022...
-
March 15, 2022
L'accord de distribution mondiale conclu avec Saladax Biomedical permet aux clients de Beckman Coulter d'accéder aux tests. PARIS, FRANCE, le 15 mars 2022 — Beckman Coulter, l’un des leaders...
-
March 15, 2022
Un acuerdo de distribución global con Saladax Biomedical pone a disposición de los laboratorios y profesionales sanitarios pruebas de monitorización de medicamentos antipsicóticos. Esta tecnologí
-
March 15, 2022
Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter customers BREA, Calif. , March 15, 2022 /PRNewswire/ -- Beckman...
-
March 15, 2022
Durch die globale Vertriebsvereinbarung mit Saladax Biomedical stehen den Kunden von Beckman Coulter Tests zur Überwachung therapeutisch eingesetzter antipsychotischer Medikamente zur Verfügung. Mü
September 28, 2021Beckman Coulter today announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo. The DxU Iris Workcell is a fully automated system that streamlines...
-
July 26, 2021
Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture,...
May 19, 2021Beckman Coulter, a global clinical diagnostics leader, today announced the launch of Access SARS-CoV-2 IgG (1st IS), a fully-quantitative lab-based Immunoglobulin G (IgG) serology test that...
May 4, 2021Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than...
March 23, 2021Beckman Coulter, a clinical diagnostics leader, today announced that its Access SARS-CoV-2 IgG II antibody assay received U.S. Emergency Use Authorization (EUA) from the U.S. Food and Drug...
March 18, 2021Beckman Coulter, a clinical diagnostics leader, today announced their commitment to support the U.S. government's plan to invest more than $12 billion to expand COVID-19 testing with their...
January 25, 2021Beckman Coulter, a global leader in clinical diagnostics, announced today the launch of the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to...
December 18, 2020Below is the updated press release. Beckman Coulter Launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S. The Access SARS-CoV-2 Antigen...
-
November 23, 2020
Beckman Coulter, a clinical diagnostics leader, today launched its Access SARS-CoV-2 IgG II assay that measures a patient's relative level of antibodies in response to a previous SARS-CoV-2...
- November 10, 2020
Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test...
October 15, 2020Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the...
October 9, 2020Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...
October 6, 2020Beckman Coulter, a clinical diagnostics leader, today announced research results that demonstrate its Access SARS-CoV-2 IgG assay shows excellent agreement to the Genscript SARS-CoV-2 Surrogate...
October 1, 2020Beckman Coulter today announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA). Access IL-6 is a...
August 24, 2020Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test demonstrated 99.9% specificity against...
August 5, 2020Beckman Coulter today announced new analysis from the pivotal study of its novel monocyte distribution width (MDW) hematologic biomarker for sepsis detection. The analysis showed that abnormal MDW...
July 23, 2020Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system's reagents have...
July 21, 2020Beckman Coulter, a global leader in clinical diagnostics, announced today that it received the Scientists' Choice Award® for Best New Clinical Laboratory Instrumentation of 2019 for its DxA 5000...
July 17, 2020Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories. The company's Immunoassay, Integrated Systems and Urinalysis instruments...
July 6, 2020Beckman Coulter and Lenco Diagnostic Laboratories (Lenco), one of NYC's largest privately-owned full-service reference laboratories, today announced that the first shipment of 40,000 of Beckman...
June 29, 2020Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already...
June 15, 2020La compañía ha incrementado su capacidad de fabricación y producirá 30 millones de pruebas al mes Este ensayo serológico permite detectar los anticuerpos IgG generados frente al dominio de...
- June 15, 2020
A empresa aumentou a capacidade de produção para fornecer 30 milhões de testes por mês O teste serológico deteta anticorpos IgG que visam o domínio de ligação do recetor da proteína...
- June 15, 2020
Beckman Coulter ha aumentato la capacità produttiva per raggiungere la disponibilità di 30 milioni di test al mese Il test sierologico rileva gli anticorpi IgG che riconoscono il...
- June 15, 2020
Das Unternehmen hat die Produktionskapazität zur Auslieferung von monatlich mehr als 30 Millionen Tests erhöht. Dieser serologische Test weist gegen die Rezeptor-bindende Domäne des...
- June 15, 2020
L'entreprise a augmenté sa capacité de production pour fournir 30 millions de tests par mois Le test sérologique détecte les anticorps IgG dirigés contre le domaine de liaison au récepteur...
- June 15, 2020
Brea, Calif, June 15, 2020 — Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark. The company has already shipped tests to more...
May 18, 2020Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T...
-
May 15, 2020
Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio. The partnership was awarded to...
-
April 22, 2020
Building on its strong commitment to the fight against coronavirus (COVID-19), Beckman Coulter today announced a mid-May launch timeline for its new Access SARS-CoV-2 IgG serology test and plans...
-
March 31, 2020
In response to the global COVID-19 pandemic, Beckman Coulter today announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be...
-
January 28, 2020
Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States. The...
January 7, 2020Beckman Coulter, a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 haematology analysers and the Early Sepsis Indicator...
-
October 29, 2019Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract...
-
October 21, 2019
Designed for mid-volume laboratories, Beckman Coulter’s DxH 690T offers industry-leading 93% first pass yield, and includes a 5-part differential and the Early Sepsis Indicator Brea, Calif., Oct...
October 9, 2019Beckman Coulter, a global leader in clinical diagnostics, announced today that the DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is now available for sale in...
August 7, 2019Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' Choice Award® for Best New Clinical...
August 6, 2019Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a RowBeckman Coulter announced that its MicroScan WalkAway family of instruments has once again received IMV ServiceTrak's "Best System Performance" award in the AST/ID category. ServiceTrak™...
August 1, 2019Beckman Coulter today announced that at the 71st Annual AACC conference it will showcase its clinical chemistry, immunoassay, hematology, urinalysis and microbiology solutions, configured in the...
-
May 2, 2019
The DxA 5000 delivers rapid and consistent turnaround time, provides the industry’s most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency BREA, Calif....
April 18, 2019A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter today announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug...
-
March 26, 2019
Le dosage Access PCT vient renforcer le plus vaste portefeuille de tests de diagnostic in vitro du secteur pour l'identification et la gestion du sepsis BREA, Californie, 26 mars 2019 /PRNewswire/ --
